However, the role of E-cadherin in the diagnosis and treatment of colorectal cancer, as a personalized medicine strategy, still requires comprehensive prospective clinical evaluations to precisely target the most optimal therapies for the right patients at the best time. The gene discussed is CDH1; the disease is colorectal cancer.